より高品質なmRNAワクチン開発用試薬を発売 タカラバイオ株式会社は、より高品質なmRNAを効率的に合成できる高機能な試薬「Takara IVTpro(TM)mRNA Synthesis System(low dsRNA)」（製品コード6131、以下、本試薬）およびその関連試薬を本年7月17日に発売します。 新型 ...

タカラバイオ株式会社は、mRNA合成を効率的に行うためのmRNAワクチン開発用試薬「Takara IVTpro（TM） mRNA Synthesis System」、「T7 RNA Polymerase ver.2.0」、「Pyrophosphatase（inorganic）」をいずれも研究用試薬として本日より発売します。 mRNAは、細胞内でゲノムの遺伝情報 ...

New York, USA, June 25, 2025 (GLOBE NEWSWIRE) -- Global mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~4% by 2032 | DelveInsight The growing incidence of infectious ...

Global mRNA Synthesis and Manufacturing Market OverviewThe global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast ...

According to SNS Insider, the global mRNA synthesis raw material market was valued at USD 1.70 billion in 2024 and is projected to reach USD 2.67 billion by 2032, at a compound annual growth rate ...

The COVID-19 pandemic thrust messenger RNA (mRNA) into the spotlight, underscoring its promise as a nimble, programmable platform for delivering genetic instructions directly to cells. The success of ...

Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...

CD Bioparticles launches specialized RNA Synthesis services for researchers to develop next-generation mRNA vaccines, gene therapies, and RNA-based therapeutics.

米国ではワクチン懐疑論者のロバート・F・ケネディ・ジュニア保健福祉省（HHS）長官のもと、mRNAコロナ（COVID19）ワクチン推奨の一部変更やmRNAワクチン開発への助成中止など、mRNAワクチンは逆風にさらされている。 しかし「mRNAワクチンが、免疫 ...

(MENAFN- GlobeNewsWire - Nasdaq) Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements ...